Liu Xinhui, Lu Jiandong, Liu Siqi, Huang Dakun, Chen Mianxiong, Xiong Guoliang, Li Shunmin
Department of Nephrology, Shenzhen Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine Shenzhen 518033, Guangdong, China.
Department of Urology, Shenzhen Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine Shenzhen 518033, Guangdong, China.
Am J Transl Res. 2020 Mar 15;12(3):989-998. eCollection 2020.
Huangqi-Danshen decoction (HDD) is composed of Astragali Radix (Huang-qi) and Salviae Miltiorrhizae Radix et Rhizoma (Dan-shen), both of which are the most commonly used herbs for the clinical treatment of diabetic nephropathy (DN) in traditional Chinese medicine and show good efficacy. However, the underlying mechanism of this effect is unclear. The aim of this study was to evaluate the effect and potential mechanism of HDD in the treatment of DN in a type 2 diabetic animal model, mice. HDD extract was administered orally to mice at a dose of 6.8 g/kg/day for 12 weeks. At the end of the study, serum, urine, and kidney samples were collected for biochemical and pathological examination. The expression of proteins associated with mitochondrial fission and mitophagy was determined by quantitative real-time PCR, Western blotting, and immunohistochemical analysis. The results showed that treatment with HDD substantially reduced urinary albumin excretion and improved renal injury in mice. Moreover, mitochondrial fission was increased in the kidneys of the mice, as evidenced by enhanced expression of dynamin-related protein 1 and mitochondrial morphological changes. Furthermore, PTEN-induced putative kinase 1 (PINK1)/Parkin-mediated mitophagy was activated in the mice, which manifested as increased protein expression and obvious autophagic vacuole encapsulating mitochondria. HDD treatment significantly reversed the enhanced mitochondrial fission and PINK1/Parkin-mediated mitophagy in the mice. In conclusion, this work suggested that HDD could protect against type 2 diabetes-induced kidney injury possibly by inhibiting PINK1/Parkin-mediated mitophagy.
黄芪丹参汤(HDD)由黄芪和丹参组成,这两味药是中医临床治疗糖尿病肾病(DN)最常用的草药,且疗效显著。然而,其作用的潜在机制尚不清楚。本研究旨在评估黄芪丹参汤对2型糖尿病动物模型小鼠糖尿病肾病的治疗作用及潜在机制。将黄芪丹参汤提取物以6.8 g/kg/天的剂量口服给予小鼠,持续12周。在研究结束时,收集血清、尿液和肾脏样本进行生化和病理检查。通过定量实时PCR、蛋白质印迹法和免疫组织化学分析测定与线粒体分裂和线粒体自噬相关的蛋白质表达。结果表明,黄芪丹参汤治疗可显著降低小鼠尿白蛋白排泄量并改善肾损伤。此外,小鼠肾脏中的线粒体分裂增加,这可通过动力相关蛋白1表达增强和线粒体形态变化得到证实。此外,PTEN诱导激酶1(PINK1)/Parkin介导的线粒体自噬在小鼠中被激活,表现为蛋白质表达增加和明显的包裹线粒体的自噬泡。黄芪丹参汤治疗显著逆转了小鼠线粒体分裂增强和PINK1/Parkin介导的线粒体自噬。总之,本研究表明黄芪丹参汤可能通过抑制PINK1/Parkin介导的线粒体自噬来预防2型糖尿病诱导的肾损伤。